Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

In vitro Biological Characterization of IFN-β-1a major Glycoforms.
The NOX1/4 Inhibitor GKT136901 as Selective and Direct Scavenger of Peroxynitrite.
Genmab collaborator GSK starts new ofatumumab Phase III study in rare skin disorder
Tysabri
High dose naltrexone for dyskinesias induced by levodopa.
Secret talk between adipose tissue and central nervous system via secreted factors-an emerging frontier in the neurodegenerative research.
Safety and Efficacy of Orally Administered Laquinimod Versus Placebo for Treatment of Relapsing Remitting Multiple Sclerosis (RRMS) (ALLEGRO)
Paediatric acquired demyelinating syndromes: incidence, clinical and magnetic resonance imaging features.
Ustekinumab induction and maintenance therapy in refractory Crohn's disease.
Comparative injection-site pain and tolerability of subcutaneous serum-free formulation of interferonβ-1a versus subcutaneous interferonβ-1b: results of the randomized, multicenter, Phase IIIb REFORMS study.
Protective Associations of HDL with Blood Brain Barrier Injury in Multiple Sclerosis Patients.
Meralgia paresthetica after subcutaneous injection of glatiramer acetate.
Study Suggests Targeting B Cells May Help with MS
Endogenous retroviruses and multiple sclerosis--new pieces to the puzzle.
Imaging Microglial/Macrophage Activation in Spinal Cords of Experimental Autoimmune Encephalomyelitis Rats by Positron Emission Tomography Using the Mitochondrial 18 kDa Translocator Protein Radioligand [18F]DPA-714.
Ophthalmic Evaluations in Clinical Studies of Fingolimod (FTY720) in Multiple Sclerosis.
Recombinant T Cell Receptor Ligands Improve Outcome After Experimental Cerebral Ischemia.
Physiopathology of symptoms and signs in multiple sclerosis.
Laquinimod reduces neuroaxonal injury through inhibiting microglial activation.
Estimation of the effect of dalfampridine on health utility by mapping the MSWS-12 to the EQ-5D in multiple sclerosis patients.
Chronic cerebrospinal venous insufficiency: masked multimodal imaging assessment.
HERV-W envelope protein inhibits oligodendroglial precursor cell differentiation.
Medicare Part D payments for neurologist-prescribed drugs.
Death receptor 6 negatively regulates oligodendrocyte survival, maturation and myelination.
MS related employment and disease modifying treatment in the German working population: 1994-2009.

Pages